Epocrates 

Epocrates is a renowned reference platform developed to enhance clinical decision-making and streamline the workflow of healthcare providers globally. Founded in 1998, Epocrates originally distinguished itself as one of the earliest mobile drug reference tools, first appearing as a Palm Pilot application and quickly becoming an indispensable resource in medical circles. Today, it has evolved into a sophisticated and comprehensive suite of mobile and web-based tools trusted by millions of clinicians—including physicians, pharmacists, nurse practitioners, and medical students. Epocrates serves as a continually updated, evidence-based drug and clinical information database. The platform provides instant access to detailed prescribing information for thousands of prescription medications, over-the-counter drugs, and alternative medicines. Users rely on Epocrates for real-time guidance on drug dosing, safety profiles, contraindications, and pharmacokinetics, ensuring safer and more effective prescribing at the point of care. Its deep database is paired with extensive pill identification tools, drug interaction checkers, and adverse reaction resources. These features empower clinicians to quickly resolve clinical questions, identify unknown medications from imprint codes or physical descriptions, and detect potentially dangerous drug-drug or drug-condition interactions with only a few taps. In addition to drug reference content, Epocrates integrates a host of clinical calculators and diagnostic algorithms to support rapid, evidence-based patient assessments. The app’s medical calculators cover a range of common needs—from Body Mass Index (BMI) calculations, renal function estimation, and corrected QT interval calculations to complex risk scoring systems for cardiovascular disease and sepsis. Laboratory and diagnostic test references further support clinicians in interpreting results, while decision trees and guideline summaries simplify the application of best-practice clinical protocols. Epocrates also stands out for its healthcare plan and insurance formulary integration. Clinicians can quickly check the insurance coverage status for medications, reviewing preferred alternatives for thousands of U.S. health plans. This promotes more cost-effective prescribing and can help reduce delays associated with insurance denials or prior authorizations, directly supporting medication adherence in patients. Maintaining up-to-date knowledge is central to medical professionalism, and Epocrates helps clinicians meet this requirement with curated news, medical bulletins, and free continuing medical education (CME) activities. Healthcare professionals can earn CME credits directly within the app, streamlining ongoing professional licensure requirements. Additionally, the app supports antimicrobial stewardship through geolocated susceptibility data, which empowers users to select the best empiric antibiotics based on local pathogen resistance trends, helping to curb the spread of antibiotic resistance.

Epocrates solidifies its status as a leading clinical reference app by combining a user-first design with the most trusted, rapidly accessible medical and drug information for healthcare professionals. Its key competitive advantages stem from a blend of authoritative content, robust features, high reliability, and outstanding usability—factors that have made Epocrates a preferred tool among millions of physicians, pharmacists, nurses, and medical students worldwide. Epocrates excels at delivering authoritative, continuously updated drug and disease reference information. Its database encompasses thousands of brand-name, generic, and over-the-counter medications, complete with evidence-based guidance on dosing, safety, contraindications, and interactions. What sets Epocrates apart is the speed and reliability of its information delivery—clinicians can access critical prescribing details, drug interaction checks, and pill identifiers at the point of care within seconds, minimizing cognitive load and reducing the risk of medication errors.

• Small Businesses (1-99)
• Mid Market (100-500)
• Enterprise (500+)